Expertise in
3
conditions

Lucy D. Burr

Aubigny Place, 
South Brisbane, QLD, AU 
Expertise in
3
conditions
Aubigny Place, 
South Brisbane, QLD, AU 

Overview

Lucy Burr practices in South Brisbane, Australia. Mr. Burr is highly rated in 3 conditions, according to our data. His top areas of expertise are Bronchiectasis, Cystic Fibrosis, Pseudomonas Stutzeri Infections, and Asthma.

His clinical research consists of co-authoring 51 peer reviewed articles and participating in 3 clinical trials. MediFind looks at clinical research from the past 15 years.

Gender

Male

Locations

Aubigny Place, South Brisbane, QLD, Australia

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

3 Clinical Trials

APPLAUD: A Double-Blind, Randomized, Placebo-Controlled, Phase II Study of the Efficacy and Safety of LAU-7b in the Treatment of Cystic Fibrosis in Adults
APPLAUD: A Double-Blind, Randomized, Placebo-Controlled, Phase II Study of the Efficacy and Safety of LAU-7b in the Treatment of Cystic Fibrosis in Adults
Enrollment Status: Completed
Publish Date: October 09, 2024
Intervention Type: Drug
Study Drug: Fenretinide
Study Phase: Phase 2
A Five Part Phase 1 Study to Assess the Safety, Tolerability and Pharmacokinetic (PK) Profile of Single and Repeat Oral Doses of FDL176 in Healthy and Cystic Fibrosis (CF) Participants
A Five Part Phase 1 Study to Assess the Safety, Tolerability and Pharmacokinetic (PK) Profile of Single and Repeat Oral Doses of FDL176 in Healthy and Cystic Fibrosis (CF) Participants
Enrollment Status: Completed
Publish Date: September 06, 2018
Intervention Type: Drug
Study Phase: Phase 1
A Randomized, Double-Blind, Placebo-Controlled, Parallel Study to Evaluate Safety, Pharmacokinetics (PK) and Pharmacodynamics(PD) of FDL169 in Cystic Fibrosis (CF) Subjects Homozygous for the F508del-CFTR Mutation
A Randomized, Double-Blind, Placebo-Controlled, Parallel Study to Evaluate Safety, Pharmacokinetics (PK) and Pharmacodynamics(PD) of FDL169 in Cystic Fibrosis (CF) Subjects Homozygous for the F508del-CFTR Mutation
Enrollment Status: Completed
Publish Date: April 12, 2018
Intervention Type: Drug
Study Phase: Phase 1
View 2 Less Clinical Trials

51 Total Publications

The Worldwide Puzzle of Bronchiectasis Etiology in Adults.
The Worldwide Puzzle of Bronchiectasis Etiology in Adults.
Journal: Archivos de bronconeumologia
Published: September 16, 2025

Frequently Asked Questions about Lucy D. Burr

Is Lucy D. Burr a top-rated expert for Bronchiectasis?

MediFind is an objective health platform that identifies experts based on real-world data. Lucy D. Burr is classified as an Elite expert for Bronchiectasis, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.

Does Lucy D. Burr participate in research or clinical trials?

Yes. Lucy D. Burr has published 51 articles and abstracts on conditions like Bronchiectasis. You can view a list of Lucy D. Burr's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Mr. Burr's expertise for a condition
ConditionClose
Want to save this expert for later?
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
 
 
 
 
Learn about our expert tiers
Learn More
Are you the provider on this profile?
Claim Profile